No major cognitive impairment in young children with acute lymphoblastic leukemia using chemotherapy only: A prospective longitudinal study

American Journal of Pediatric Hematology/Oncology

Volumn 24, Issue 2, 2002, Pages 106-114

  Kingma, Annette ^a   Van Dommelen, Rieneke I ^a   Mooyaart, Eduard L ^a   Wilmink, Jan T ^b   Deelman, Betto G ^a   Kamps, Willem A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Chemotherapy only; Childhood acute lymphoblastic leukemia; Neuropsychological late effects; Prospective study; School career

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACADEMIC ACHIEVEMENT; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PSYCHOMETRY; SCORING SYSTEM; TREATMENT OUTCOME;

6-MERCAPTOPURINE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; ATTENTION; CHILD, PRESCHOOL; COGNITION DISORDERS; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IFOSFAMIDE; INJECTIONS, SPINAL; LEARNING DISORDERS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LONGITUDINAL STUDIES; MALE; METHOTREXATE; NETHERLANDS; NEUROPSYCHOLOGICAL TESTS; PREDNISONE; PROSPECTIVE STUDIES; SURVIVORS; TENIPOSIDE; TREATMENT OUTCOME; VINCRISTINE;

EID: 0036173563     PISSN: 01928562     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200202000-00010     Document Type: Article

References (34)

1. Pinkel D. Lessons from 20 years of curative therapy of childhood acute leukemia. Br J Cancer 1992; 65: 148-53.
2. Fletcher JM, Copeland DR. Neurobehavioral effects of central nervous system prophylactic treatment of cancer in children. J Clin Exp Neuropsychol 1988; 10: 495-537.
3. Roman DD, Sperduto PW. Neuropsychologic effects of cranial radiation: current knowledge and future directions. Int J Radiat Oncol Biol Phys 1995; 31: 983-98.
4. Williams J, Davis KS. Central nervous system prophylactic treatment of childhood leukemia: neuropsychologic outcome studies. Cancer Treatment Rev 1986; 13: 113-27.
5. Cousens P, Waters B, Said J, Stevens M. Cognitive effects of cranial irradiation in leukemia: a survey and meta-analysis. J Child Psychol Psychiatr 1988; 6: 839-52.
6. Stebhens JA, Kaleita TA, Noll RB. Central nervous system prophylaxis of childhood leukemia: what are the long term neuropsychologic, neurologic and behavioral effects? Neuropsychol Rev 1991; 2: 147-77.
7. Madan-Swain A, Brown RT. Cognitive and psychosocial sequelae for children with acute lymphoblastic leukemia and their families. Clin Psychol Rev 1991; 11: 267-94.
8. Brown RT, Madan-Swain A, Pais R, et al. Chemotherapy for ALL: cognitive and academic sequelae. J Pediatr 1992; 121: 885-89.
9. Brown RT, Sawyer MB, Antoniou G et al. A 3-year follow-up of the intellectual and academic functioning of children receiving central nervous system prophylactic chemotherapy for leukemia. J Dev Behav Pediatr 1996; 17: 392-8.
10. Brown RT, Madan-Swain A, Walco GA, et al. Cognitive and academic late effects among children previously treated for acute lymphocytic leukemia receiving chemotherapy as central nervous system prophylaxis. J Pediatr Psychol 1998; 23: 333-40.
11. Ochs J, Mulhern RK, Fairclough D, et al. Comparison of neuropsychologic functioning and clinical indicators of neurotoxicity in longterm survivors of childhood leukemia given cranial irradiation or parenteral methotrexate: a prospective study. J Clin Oncol 1991; 1: 145-51.
12. Mulhern RK, Wasserman AL, Fairclough D, Ochs J. Memory function in disease-free survivors of childhood acute lymphocytic leukemia given central nervous system prophylaxis with or without 1800 cGy cranial irradiation. J Clin Oncol 1988; 6: 315-20.
13. Copeland DR, Moore BD, Francis DJ, et al. Neuropsychologic effects of chemotherapy on children with cancer: a longitudinal study. J Clin Oncol 1996; 14: 2826-35.
14. Butler RW, Hill JM, Steinherz PG, et al. Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer. J Clin Oncol 1994; 12: 2621-9.
15. Anderson V, Smibert E, Ekert H, Godbert T. Intellectual, educational and behavioral sequelae after cranial irradiation and chemotherapy. Arch Dis Child 1994; 70: 476-83.
16. Kingma A. Neuropsychologic effects of cancer therapy: cerebral pathology, cognitive impairment and school re-entry. In: Pochedly C, ed. Neoplastic diseases of childhood. 1st ed. Chur., Switzerland: Harwood Academic Publishers; 1994: 1497-520.
17. Butler RW, Copeland DR. Neuropsychologic effects of central nervous system prophylactic treatment in childhood leukemia: methodological considerations. J Pediatr Psychol 1993; 18: 319-38.
18. Kamps WA, Bokkerink JP, Hählen K, et al. Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: results of Dutch Childhood Leukemia Study Group Protocol ALL-7 (1988-1991). Blood 1999; 94: 1226-36.
19. Wechsler D. Manual Wechsler Preschool and Primary Scale of Intelligence. New York: The Psychological Corp.; 1967.
20. Wechsler D. Wechsler Intelligence Scale for Children-revised. New York: The Psychological Corp,; 1974.
21. Bos H, De Sonneville LMJ. De Nederlandse WISC-R. Kind Adolesc 1989; 10: 72-9.
22. Flynn JR. Massive IQ gains in 14 nations: what IQ tests really measure. Psychol Bull 1984; 101: 171-91.
23. Van der Burg W, Kingma A. Performance of 225 Dutch school children on Rey’s Auditory Verbal Learning Test (AVLT): parallel test-retest reliabilities with an interval of 3 months: normative data. Arch Clin Neuropsychol 1999; 14: 545-59.
24. Kamphuis GH. Een bijdrage tot de geschiedenis van de Bourdontest. Ned Tijdschr Psychol 1962; 17: 247-50.
25. Lezak MD. Neuropsychologic assessment, 3rd edn. New York: Oxford University Press; 1995.
26. Beery KE. Revised administration, scoring and searching manual for the development test of visual-motor integration. Cleveland: Modern Curriculum Press; 1982.
27. Gardner RA, Broman M. The Purdue Pegboard; normative data on 1334 schoolchildren. J Clin Child Psychol 1979; 8: 156-62.
28. Veerman AJP, Hählen K, Kamps WA, et al. High cure rate with moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia: results of protocol ALL VI (1984-1988) from the Dutch Childhood Leukemia Study Group. J Clin Oncol 1996; 3: 911-8.
29. Runyon A, Haber B. Fundamentals of behavior statistics. Reading: Addison-Wesley; 1967.
30. Spreen O, Strauss E. A compendium of neuropsychologic tests. New York: Oxford University Press; 1998.
31. Sanders-Woudstra JAR, Verhulst FC, De Witte HTJ. Kinder-en Jeugdpsychiatrie I. Assen: Van Gorcum; 1995.
32. Waber DP, Carpentieri SC, Klar N et al. Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or prednisone. J Pediatr Hematol Oncol 2000; 22: 206-13.
33. Mulhern RK, Fairclough D, Ochs J. A prospective comparison of neuropsychologic performance of children surviving leukemia who received 18-Gy, 24 Gy, or no cranial irradiation. J Clin Oncol 1991; 9: 1348-56.
34. CBS. Enquete beroepsbevolking 1995 Centraal Bureau voor de Statistiek. Heerlen: CBS, Div. Sociaal-Economische Statistieken; 1996.